These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32914347)

  • 1. Safety, effectiveness and mid-term follow-up in 136 consecutive patients with moderate to severely calcified lesions undergoing phoenix atherectomy.
    Giusca S; Lichtenberg M; Schueler M; Heinrich U; Eisenbach C; Andrassy M; Korosoglou G
    Heart Vessels; 2021 Mar; 36(3):366-375. PubMed ID: 32914347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phoenix atherectomy for patients with peripheral artery disease.
    Giusca S; Hagstotz S; Lichtenberg M; Heinrich U; Eisenbach C; Andrassy M; Korosoglou G
    EuroIntervention; 2022 Aug; 18(5):e432-e442. PubMed ID: 35389346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Foley TR; Cotter RP; Kokkinidis DG; Nguyen DD; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Therapeutic Concepts for Complex Femoropopliteal Lesions Using the Jetstream Atherectomy System.
    Dukic D; Martin K; Lichtenberg M; Brodmann M; Andrassy J; Korosoglou G; Andrassy M
    J Endovasc Ther; 2023 Mar; ():15266028231161246. PubMed ID: 36960883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: One-year single centre clinical results.
    Cioppa A; Stabile E; Popusoi G; Salemme L; Cota L; Pucciarelli A; Ambrosini V; Sorropago G; Tesorio T; Agresta A; Biamino G; Rubino P
    Cardiovasc Revasc Med; 2012; 13(4):219-23. PubMed ID: 22632996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of Phoenix atherectomy for endovascular treatment in calcified common femoral artery lesions.
    Kronlage M; Erbel C; Lichtenberg M; Heinrich U; Katus HA; Frey N; Giusca S; Korosoglou G
    Vasa; 2021 Sep; 50(5):378-386. PubMed ID: 34155913
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of ante-versus retrograde access for the endovascular treatment of long and calcified, de novo femoropopliteal occlusive lesions.
    Giusca S; Lichtenberg M; Hagstotz S; Eisenbach C; Katus HA; Erbel C; Korosoglou G
    Heart Vessels; 2020 Mar; 35(3):346-359. PubMed ID: 31531718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM; Hyder ON; Soukas PA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.
    Zeller T; Langhoff R; Rocha-Singh KJ; Jaff MR; Blessing E; Amann-Vesti B; Krzanowski M; Peeters P; Scheinert D; Torsello G; Sixt S; Tepe G;
    Circ Cardiovasc Interv; 2017 Sep; 10(9):e004848. PubMed ID: 28916599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions.
    Kokkinidis DG; Jawaid O; Cantu D; Martinsen BJ; Igyarto Z; Valle JA; Waldo SW; Armstrong EJ
    J Endovasc Ther; 2020 Jun; 27(3):492-501. PubMed ID: 32364000
    [No Abstract]   [Full Text] [Related]  

  • 11. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
    J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lesion location on procedural and acute angiographic outcomes in patients with critical limb ischemia treated for peripheral artery disease with orbital atherectomy: A CONFIRM registries subanalysis.
    Lee MS; Mustapha J; Beasley R; Chopra P; Das T; Adams GL
    Catheter Cardiovasc Interv; 2016 Feb; 87(3):440-5. PubMed ID: 26649816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orbital Atherectomy Prior to Drug-Coated Balloon Angioplasty in Calcified Infrapopliteal Lesions: A Randomized, Multicenter Pilot Study.
    Zeller T; Giannopoulos S; Brodmann M; Werner M; Andrassy M; Schmidt A; Blessing E; Tepe G; Armstrong EJ
    J Endovasc Ther; 2022 Dec; 29(6):874-884. PubMed ID: 35086385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease.
    Stavroulakis K; Schwindt A; Torsello G; Beropoulis E; Stachmann A; Hericks C; Bollenberg L; Bisdas T
    J Endovasc Ther; 2018 Feb; 25(1):92-99. PubMed ID: 29251204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subanalysis of the CONFIRM Registries: Acute Procedural Outcomes in Claudicant and Critical Limb Ischemia Patients With Varying Levels of Calcification Treated for Peripheral Arterial Disease With Orbital Atherectomy.
    Adams GL; Das T; Lee MS; Beasley R; Mustapha J
    J Invasive Cardiol; 2015 Nov; 27(11):516-20. PubMed ID: 26524206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Safety and Efficacy of Rotational Atherectomy in Japanese Patients with Peripheral Arterial Disease Presenting Femoropopliteal Lesions: The J-SUPREME and J-SUPREME II Trials.
    Iida O; Urasawa K; Shibata Y; Yamamoto Y; Ando H; Fujihara M; Nakama T; Miyashita Y; Mori S; Diaz-Cartelle J; Soga Y
    J Endovasc Ther; 2022 Apr; 29(2):240-247. PubMed ID: 34510954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries.
    Mohapatra A; Saadeddin Z; Bertges DJ; Madigan MC; Al-Khoury GE; Makaroun MS; Eslami MH
    J Vasc Surg; 2020 Feb; 71(2):560-566. PubMed ID: 31405761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single-Center Experience With Phoenix Atherectomy System in Patients With Moderate to Heavily Calcified Femoropopliteal Lesions.
    Gandini R; Pratesi G; Merolla S; Scaggiante J; Chegai F
    Cardiovasc Revasc Med; 2020 May; 21(5):676-681. PubMed ID: 31488361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical appraisal of the contemporary use of atherectomy to treat femoropopliteal atherosclerotic disease.
    Gupta R; Siada S; Lai S; Al-Musawi M; Malgor EA; Jacobs DL; Malgor RD
    J Vasc Surg; 2022 Feb; 75(2):697-708.e9. PubMed ID: 34303802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular Treatment of Severely Calcified Femoropopliteal Lesions Using the "Pave-and-Crack" Technique: Technical Description and 12-Month Results.
    Dias-Neto M; Matschuck M; Bausback Y; Banning-Eichenseher U; Steiner S; Branzan D; Staab H; Varcoe RL; Scheinert D; Schmidt A
    J Endovasc Ther; 2018 Jun; 25(3):334-342. PubMed ID: 29557221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.